Navigation Links
Reportlinker Adds Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017
Date:4/12/2011

NEW YORK, April 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017

http://www.reportlinker.com/p0479892/Cardiac-Markers---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecast-to-2017.html

Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017

Summary

GlobalData's new report, "Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global cardiac markers market. The report provides market landscape, competitive landscape and market trends information on the cardiac markers market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2009.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within cardiac markers market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthcare, Alere and Beckman Coulter.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the cardiac markers market globally.

- Design and develop your product development, marketing and sales strategies.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next big thing in the cardiac markers market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global cardiac markers market and the factors shaping it.

1 Table of contents

1 Table of contents 3

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 GlobalData Report Guidance 7

3 Cardiovascular Disease Overview 8

3.1 Pathophysiology 8

3.2 Disease Burden 9

3.3 Diagnosis 10

4 Cardiac Markers: Market Characterization 11

4.1 Cardiac Markers Market, Global, Revenue ($m), Historic, 2003-2010 11

4.2 Cardiac Markers Market, Global, Revenue ($m), Forecast, 2010-2017 12

4.3 Cardiac Markers, Key Trends 13

4.3.1 Lab-on--a Chip Cardiac Sensor System 13

4.3.2 Use of Predictive Markers for Personalized Treatment 13

4.3.3 High-Sensitivity CRP (hs-CRP) 14

4.3.4 Heart-Type Fatty Acid Binding Protein (H-FABP) 14

4.3.5 Cardiac Biomarker Soluble ST2 (sST2) Exhibits Significant Clinical Value 15

4.3.6 Myeloperoxidase (MPO) 15

4.3.7 Brain Natriuretic Peptide (BNP) 15

4.4 Cardiac Markers, Market Dynamics 16

4.4.1 Cardiac Markers, Market Drivers 16

4.4.2 Cardiac Markers Market Restraints 18

5 Global Cardiac Markers Market, by Country, Revenue ($m), 2003-2017 19

5.1 Cardiac Markers Market, the US, Revenue ($m), Historic, 2003 – 2010 19

5.2 Cardiac Markers Market, the US, Revenue ($m), Forecast, 2010 – 2017 20

5.3 Cardiac Markers Market, Canada, Revenue ($m), Historic, 2003 – 2010 21

5.4 Cardiac Markers Market, Canada, Revenue ($m), Forecast, 2010 – 2017 22

5.5 Cardiac Markers Market, the UK, Revenue ($m), Historic, 2003 – 2010 23

5.6 Cardiac Markers Market, the UK, Revenue ($m), Forecast, 2010 – 2017 24

5.7 Cardiac Markers Market, Germany, Revenue ($m), Historic, 2003 – 2010 25

5.8 Cardiac Markers Market, Germany, Revenue ($m), Forecast, 2010 – 2017 26

5.9 Cardiac Markers Market, France, Revenue ($m), Historic, 2003 – 2010 27

5.10 Cardiac Markers Market, France, Revenue ($m), Forecast, 2010 – 2017 28

5.11 Cardiac Markers Market, Italy, Revenue ($m), Historic, 2003 – 2010 29

5.12 Cardiac Markers Market, Italy, Revenue ($m), Forecast, 2010 – 2017 30

5.13 Cardiac Markers Market, Spain, Revenue ($m), Historic, 2003 – 2010 31

5.14 Cardiac Markers Market, Spain, Revenue ($m), Forecast, 2010 – 2017 32

5.15 Cardiac Markers Market, Japan, Revenue ($m), Historic, 2003 – 2010 33

5.16 Cardiac Markers Market, Japan, Revenue ($m), Forecast, 2010 – 2017 34

5.17 Cardiac Markers Market, China, Revenue ($m), Historic, 2003 – 2010 35

5.18 Cardiac Markers Market, China, Revenue ($m), Forecast, 2010 – 2017 36

5.19 Cardiac Markers Market, India, Revenue ($m), Historic, 2003 – 2010 37

5.20 Cardiac Markers Market, India, Revenue ($m), Forecast, 2010 – 2017 38

5.21 Cardiac Markers Market, Australia, Revenue ($m), Historic, 2003 – 2010 39

5.22 Cardiac Markers Market, Australia, Revenue ($m), Forecast, 2010 – 2017 40

5.23 Cardiac Markers Market, Brazil, Revenue ($m), Historic, 2003-2010 41

5.24 Cardiac Markers Market, Brazil, Revenue ($m), Forecast, 2010 – 2017 42

6 Cardiac Markers Market: Strategic Competitive Assessment 43

6.1 Cardiac Markers Market, Global, Company Share (%), 2010 43

6.2 Cardiac Markers Market, Competitive Analysis 44

6.2.1 Threat of Rivalry 44

6.2.2 Threat of New Entrants 45

6.2.3 Buyer Power 45

6.2.4 Threat of Substitute 45

6.2.5 Supplier Power 45

6.3 Cardiac Markers: Key Market Participants 46

6.3.1 F. Hoffmann-La Roche Ltd. 46

6.3.2 Abbott Laboratories 48

6.3.3 Siemens Healthcare 50

6.3.4 Alere 53

6.3.5 Beckman Coulter, Inc. 55

7 Key Marketed Cardiac Markers 58

7.1 TROP T Sensitive Rapid Assay 58

7.1.1 Product Description 58

7.1.2 Features and Benefits 58

7.2 Cobas c 111 Analyzer 58

7.2.1 Product Description 58

7.2.2 Features and Benefits 58

7.3 I-STAT System 59

7.3.1 Product Description 59

7.3.2 Features and Benefits 59

7.4 Stratus CS Analyzer 59

7.4.1 Product Description 59

7.4.2 Features and Benefits 59

7.5 TriageBNP 60

7.5.1 Product Description 60

7.5.2 Features and Benefits 60

8 Cardiac Markers Market: Strategic Pipeline Assessment 61

8.1 Device Pipeline Products Summary 61

8.2 Profiles of Promising Products Under Clinical Development 65

8.2.1 VASCLIR 65

8.2.2 ARCHITECT MPO ASSAY 66

8.2.3 CADPrint 67

8.2.4 Presage ST2 Assay 68

8.2.5 Verigene Cardiac Troponin I Assay 69

8.2.6 Lab-on-a -Film Cardiac Sensor System 71

9 Cardiac Marker Market: Strategic Deals Analysis 72

9.1 Key Acquisitions 72

9.1.1 Danaher to Acquire Beckman Coulter 72

9.1.2 bioMerieux Completed the Acquisition of Meikang Biotech (Shanghai) 72

9.1.3 Inverness Medical Innovations Acquired 78.13% Stake in Standard Diagnostics 73

9.1.4 VaxGen Completed Acquisition of diaDexus 73

9.1.5 Siemens Medical Solutions Acquired Dade Behring 73

9.2 Key Partnerships 74

9.2.1 BG Medicine Enters Into an Agreement with Siemens Healthcare Diagnostics 74

9.2.2 Axis-Shield Signs Option Agreement with Bio-Rad Laboratories 74

10 Appendix 75

10.1 Definitions 76

10.1.1 Cardiac Markers 76

10.2 Acronyms 76

10.3 Sources 77

10.4 Research Methodology 77

10.5 Secondary Research 77

10.6 Primary Research 78

10.7 Models 78

10.8 Forecasts 78

10.9 Expert Panels 79

10.10 GlobalData Consulting 79

10.11 Contact Us 79

10.12 Disclaimer 79

1.1 List of Tables

Table 1: Cardiac Markers Market, Global, Revenue ($m), 2003-2010 11

Table 2: Cardiac Markers Market, Global, Revenue ($m), 2010- 2017 12

Table 3: Pipeline hs-CRP Cardiac Markers 14

Table 4: Pipeline MPO Cardiac Markers 15

Table 5: Commercial POC Testing for Cardiac Markers 17

Table 6: Cardiac Markers Market, the US, Revenue ($m), 2003-2010 19

Table 7: Cardiac Markers Market, the US, Revenue ($m), 2010-2017 20

Table 8: Cardiac Markers Market, Canada, Revenue ($m), 2003-2010 21

Table 9: Cardiac Markers Market, Canada, Revenue ($m), 2010-2017 22

Table 10: Cardiac Markers Market, the UK, Revenue ($m), 2003-2010 23

Table 11: Cardiac Markers Market, the UK, Revenue ($m), 2010-2017 24

Table 12: Cardiac Markers Market, Germany, Revenue ($m), 2003-2010 25

Table 13: Cardiac Markers Market, Germany, Revenue ($m), 2010-2017 26

Table 14: Cardiac Markers Market, France, Revenue ($m), 2003-2010 27

Table 15: Cardiac Markers Market, France, Revenue ($m), 2010-2017 28

Table 16: Cardiac Markers Market, Italy, Revenue ($m), 2003-2010 29

Table 17: Cardiac Markers Market, Italy, Revenue ($m), 2010-2017 30

Table 18: Cardiac Markers Market, Spain, Revenue ($m), 2003-2010 31

Table 19: Cardiac Markers Market, Spain, Revenue ($m), 2010-2017 32

Table 20: Cardiac Markers Market, Japan, Revenue ($m), 2003-2010 33

Table 21: Cardiac Markers Market, Japan, Revenue ($m), 2010-2017 34

Table 22: Cardiac Markers Market, China, Revenue ($m), 2003-2010 35

Table 23: Cardiac Markers Market, China, Revenue ($m), 2010-2017 36

Table 24: Cardiac Markers Market, India, Revenue ($m), 2003-2010 37

Table 25: Cardiac Markers Market, India, Revenue ($m), 2010-2017 38

Table 26: Cardiac Markers Market, Australia, Revenue ($m), 2003-2010 39

Table 27: Cardiac Markers Market, Australia, Revenue ($m) , 2010-2017 40

Table 28: Cardiac Markers Market, Brazil, Revenue ($m), 2003-2010 41

Table 29: Cardiac Markers Market, Brazil, Revenue ($m), 2010-2017 42

Table 30: Cardiac Markers Market, Global, Key Company Revenue ($m), 2010 43

Table 31: F. Hoffman-La-Roche, Marketed Products, 2010 46

Table 32: F. Hoffman-La-Roche, Pipeline Products, 2010 46

Table 33: Abbott Laboratories, Marketed Products 48

Table 34: Abbott Laboratories, Pipeline Products 48

Table 35: Siemens Healthcare, Marketed Products, 2010 50

Table 36: Siemens Healthcare, Pipeline Products, 2010 50

Table 37: Beckman Coulter, Inc, Marketed Products 55

Table 38: Beckman Coulter Inc, Pipeline Products, 2010 56

Table 39: TROP T Sensitive Rapid Assay, Features and Benefits 58

Table 40: Cobas c 111 Analyzer, Features and Benefits 58

Table 41: i-STAT System, Features and Benefits 59

Table 42: Stratus CS Analyzer, Features and Benefits 59

Table 43: TriageBNP, Features and Benefits 60

Table 44: Cardiac Markers Market, Global, Pipeline Products 61

Table 45: Cardiac Markers Market, List of Pipeline Products in Clinical Development 62

Table 46: Cardiac Markers Market, List of Pipeline Products in Early Development 63

Table 47: Cardiac Markers Market, List of Pipeline Products 64

Table 48: VASCLIR, Product Status, 2010 65

Table 49: VASCLIR, Clinical Trials, 2010 65

Table 50: ARCHITECT MPO ASSAY, Product Status, 2010 66

Table 51: Architect MPO Assay, Clinical Trials, 2010 66

Table 52: CADPrint, Product Status, 2010 67

Table 53: CADPrint, Clinical Trials, 2010 67

Table 54: PresageAssay ST2, Product Status, 2010 68

Table 55: PresageAssay ST2, Clinical Trial, 2010 68

Table 56: Verigene Cardiac Troponin I Assay, Product Status, 2010 69

Table 57:Verigene Cardiac Troponin I Assay, Clinical Trial, 2010 69

Table 58:Lab-on-a Film Cardiac Sensor System, Product Status 71

1.2 List of Figures

Figure 1: Cardiovascular Diseases, Pathphysiology 8

Figure 2: Cardiovascular Disease Burden, Global, 2010 9

Figure 3: Cardiac Markers Market, Global, Revenue ($m), 2003-2010 11

Figure 4: Cardiac Markers Market, Global, Revenue ($m), 2010- 2017 12

Figure 5: Diagnostic Work Flow Diagram for Underlying Personalized Medicine 13

Figure 6: Cardiac Markers Market, Global, Market Dynamics 16

Figure 7: Cardiac Markers Market, the US, Revenue ($m), 2003-2010 19

Figure 8: Cardiac Markers Market, the US, Revenue ($m), 2010-2017 20

Figure 9: Cardiac Markers Market, Canada, Revenue ($m), 2003-2010 21

Figure 10: Cardiac Markers Market, Canada, Revenue ($m), 2010-2017 22

Figure 11: Cardiac Markers Market, the UK, Revenue ($m), 2003-2010 23

Figure 12: Cardiac Markers Market, the UK, Revenue ($m), 2010-2017 24

Figure 13: Cardiac Markers Market, Germany, Revenue ($m), 2003-2010 25

Figure 14: Cardiac Markers Market, Germany, Revenue ($m), 2010-2017 26

Figure 15: Cardiac Markers Market, France, Revenue ($m), 2003-2010 27

Figure 16: Cardiac Markers Market, France, Revenue ($m), 2010-2017 28

Figure 17: Cardiac Markers Market, Italy, Revenue ($m), 2003-2010 29

Figure 18: Cardiac Markers Market, Italy, Revenue ($m), 2010-2017 30

Figure 19: Cardiac Markers Market, Spain, Revenue ($m), 2003-2010 31

Figure 20: Cardiac Markers Market, Spain, Revenue ($m), 2010-2017 32

Figure 21: Cardiac Markers Market, Japan, Revenue ($m), 2003-2010 33

Figure 22: Cardiac Markers Market, Japan, Revenue ($m), 2010-2017 34

Figure 23: Cardiac Markers Market, China, Revenue ($m), 2003-2010 35

Figure 24: Cardiac Markers Market, China, Revenue ($m), 2010-2017 36

Figure 25: Cardiac Markers Market, India, Revenue ($m), 2003-2010 37

Figure 26: Cardiac Markers Market, India, Revenue ($m), 2010-2017 38

Figure 27: Cardiac Markers Market, Australia, Revenue ($m), 2003-2010 39

Figure 28: Cardiac Markers Market, Australia, Revenue ($m), 2010-2017 40

Figure 29: Cardiac Markers Market, Brazil, Revenue ($m), 2003-2010 41

Figure 30: Cardiac Markers Market, Brazil, Revenue ($m), 2010-2017 42

Figure 31: Cardiac Markers Market, Global, Key Company Share, 2010 43

Figure 32: Cardiac Markers Market, Competitive Analysis 44

Figure 33: F. Hoffman-La-Roche, SWOT Analysis 47

Figure 34: Abbott, SWOT Analysis 49

Figure 35: Siemens, SWOT Analysis 51

Figure 36: Alere, SWOT Analysis 54

Figure 37: Beckman Coulter, SWOT Analysis 56

Figure 38: Cardiac Markers Market, Global, Pipeline Products 61F. Hoffmann-La Roche Ltd.

Abbott Laboratories

Siemens Healthcare

Alere

Beckman Coulter, Inc.

To order this report:

: Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Fla. , Feb. 11, 2016 PLAD, ... started out 2016 with sales exceeding company targets, are ... have received their trademark from the United States Patent ... Bobby Clark , Chief Executive Officer of PLAD, Inc.  ... of Pennsylvania with two new ...
(Date:2/11/2016)... Feb. 11, 2016  Delcath Systems, Inc. (NASDAQ: ... device company focused on oncology with an emphasis ... cancers, announces the engagement of Lars E. ... Medical Consultant. Dr. Birgerson will provide strategic medical ... operations team to help ensure timely facilitation of ...
(Date:2/11/2016)... ENGLEWOOD, Colo. , Feb. 11, 2016  Aytu ... on developing treatments for urological and related conditions, announced ... for the second fiscal quarter of 2016 on Tuesday, ... will review recent accomplishments and provide an overview of ... financial results for the quarter ended December 31, 2015. ...
Breaking Medicine Technology:
(Date:2/11/2016)... Island, NY (PRWEB) , ... February 11, 2016 ... ... has enhanced and updated its hallmark resource, Infusion Therapy Standards of Practice, to ... leader in vein illumination with an estimated 85% share of the market, facilitates ...
(Date:2/11/2016)... ... February 11, 2016 , ... The annual list showcases the 20 Most Promising ... team dedication and commitment to the SharePoint ecosystem. A panel of experts and ... goal is to recognize and promote technology entrepreneurship. , The survey was made ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... dynamometers and ergoFET force gauges used in physical therapy, occupational therapy and sports ... sensor for resistance cord exercise and therapy, introduces its new microFET Digital Pinch ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... coverage results in significantly higher rates of several common cancer screenings, especially among ... in better outcomes and survival rates. , The study,“What Does Medicaid Expansion ...
(Date:2/10/2016)... ... February 10, 2016 , ... Sherly Sulaiman, certified clinical ... of therapeutic sessions to help Los Angeles-area actors cope with rejection, improve their ... series, known as “Mindfulness for Actors and Artists,” has been featured in ...
Breaking Medicine News(10 mins):